|
1
|
Parikh MP, Wadhwa V, Thota PN, Lopez R and
Sanaka MR: Outcomes associated with timing of ERCP in acute
cholangitis secondary to choledocholithiasis. J Clin Gastroenterol.
52:e97–e102. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Park JK, Woo YS, Noh DH, Yang JI, Bae SY,
Yun HS, Lee JK, Lee KT and Lee KH: Efficacy of EUS-guided and
ERCP-guided biliary drainage for malignant biliary obstruction:
Prospective randomized controlled study. Gastrointest Endosc.
88:277–282. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kochar B, Akshintala VS, Afghani E,
Elmunzer BJ, Kim KJ, Lennon AM, Khashab MA, Kalloo AN and Singh VK:
Incidence, severity, and mortality of post-ERCP pancreatitis: A
systematic review by using randomized, controlled trials.
Gastrointest Endosc. 81:143–149.e9. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
ASGE Standards of Practice Committee.
Chandrasekhara V, Khashab MA, Muthusamy VR, Acosta RD, Agrawal D,
Bruining DH, Eloubeidi MA, Fanelli RD, Faulx AL, et al: Adverse
events associated with ERCP. Gastrointest Endosc. 85:32–47.
2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ito K, Fujita N, Noda Y, Kobayashi G,
Horaguchi J, Takasawa O and Obana T: Relationship between post-ERCP
pancreatitis and the change of serum amylase level after the
procedure. World J Gastroenterol. 13:3855–3860. 2007.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Dumonceau JM, Andriulli A, Elmunzer BJ,
Mariani A, Meister T, Deviere J, Marek T, Baron TH, Hassan C,
Testoni PA, et al: Prophylaxis of post-ERCP pancreatitis: European
society of gastrointestinal endoscopy (ESGE) guideline-updated June
2014. Endoscopy. 46:799–815. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hou YC, Hu Q, Huang J, Fang JY and Xiong
H: Efficacy and safety of rectal nonsteroidal anti-inflammatory
drugs for prophylaxis against post-ERCP pancreatitis: A systematic
review and meta-analysis. Sci Rep. 7(46650)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Dumonceau JM, Kapral C, Aabakken L,
Papanikolaou IS, Tringali A, Vanbiervliet G, Beyna T, Dinis-Ribeiro
M, Hritz I, Mariani A, et al: ERCP-related adverse events: European
society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy.
52:127–149. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lamberts SWJ and Hofland L: ANNIVERSARY
REVIEW: Octreotide, 40 years later. Eur J Endocrinol.
181:R173–R183. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li ZS, Pan X, Zhang WJ, Gong B, Zhi FC,
Guo XG, Li PM, Fan ZN, Sun WS, Shen YZ, et al: Effect of octreotide
administration in the prophylaxis of post-ERCP pancreatitis and
hyperamylasemia: A multicenter, placebo-controlled, randomized
clinical trial. Am J Gastroenterol. 102:46–51. 2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Morgan D, Pandolfino J, Katz PO, Goldstein
JL, Barker PN and Illueca M: Clinical trial: Gastric acid
suppression in Hispanic adults with symptomatic gastro-oesophageal
reflux disease-comparator study of esomeprazole, lansoprazole and
pantoprazole. Aliment Pharmacol Ther. 32:200–208. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Grieco FA, Moore F, Vigneron F, Santin I,
Villate O, Marselli L, Rondas D, Korf H, Overbergh L, Dotta F, et
al: IL-17A increases the expression of proinflammatory chemokines
in human pancreatic islets. Diabetologia. 57:502–511.
2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Paajanens H, Laato M, Jaakkola M, Pulkki
K, Niinikoski J and Nordback I: Serum tumour necrosis factor
compared with C-reactive protein in the early assessment of
severity of acute pancreatitis. Br J Surg. 82:271–273.
1995.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Watanabe T, Kudo M and Strober W:
Immunopathogenesis of pancreatitis. Mucosal Immunol. 10:283–298.
2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ilone S and Fauzi A: Diagnostic and
prevention approach in post endoscopic retrograde
cholangiopancreatography pancreatitis. Indones J Gastroenterol
Hepatol Dig Endosc. 17:188–193. 2017.
|
|
16
|
Yang R, Masters AR, Fortner KA, Champagne
DP, Yanguas-Casás N, Silberger DJ, Weaver CT, Haynes L and Rincon
M: IL-6 promotes the differentiation of a subset of naive
CD8+ T cells into IL-21-producing B helper
CD8+ T cells. J Exp Med. 213:2281–2291. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kurihara T, Yasuda I, Isayama H,
Tsuyuguchi T, Yamaguchi T, Kawabe K, Okabe Y, Hanada K, Hayashi T,
Ohtsuka T, et al: Diagnostic and therapeutic single-operator
cholangiopancreatoscopy in biliopancreatic diseases: Prospective
multicenter study in Japan. World J Gastroenterol. 22:1891–1901.
2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Elmunzer BJ, Serrano J, Chak A,
Edmundowicz SA, Papachristou GI, Scheiman JM, Singh VK,
Varadurajulu S, Vargo JJ, Willingham FF, et al: Rectal indomethacin
alone versus indomethacin and prophylactic pancreatic stent
placement for preventing pancreatitis after ERCP: Study protocol
for a randomized controlled trial. Trials. 17(120)2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Thomopoulos KC, Pagoni NA, Vagenas KA,
Margaritis VG, Theocharis GI and Nikolopoulou VN: Twenty-four hour
prophylaxis with increased dosage of octreotide reduces the
incidence of post-ERCP pancreatitis. Gastrointest Endosc.
64:726–731. 2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bai Y, Ren X, Zhang XF, Lv NH, Guo XG, Wan
XJ, Nie ZG, Han ST, Bie P, Tian DA, et al: Prophylactic
somatostatin can reduce incidence of post-ERCP pancreatitis:
Multicenter randomized controlled trial. Endoscopy. 47:415–420.
2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Binmoeller KF, Harris AG, Dumas R,
Grimaldi C and Delmont JP: Does the somatostatin analogue
octreotide protect against ERCP induced pancreatitis? Gut.
33:1129–1133. 1992.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Saunders JH, Cargill JM and Wormsley KG:
Gastric secretion of acid in patients with pancreatic disease.
Digestion. 17:365–369. 1978.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kahl S and Malfertheiner P: Exocrine and
endocrine pancreatic insufficiency after pancreatic surgery. Best
Pract Res Clin Gastroenterol. 18:947–955. 2004.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Li Z, Wu C, Li L, Wang Z, Xie H, He X and
Feng J: Effect of long-term proton pump inhibitor administration on
gastric mucosal atrophy: A meta-analysis. Saudi J Gastroenterol.
23:222–228. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yoo JH, Kwon CI, Yoo KH, Yoon H, Kim WH,
Ko KH, Hong SP and Park PW: Effect of proton pump inhibitor in
patients with acute pancreatitis-pilot study. Korean J
Gastroenterol. 60:362–367. 2012.PubMed/NCBI View Article : Google Scholar : (In Korean).
|
|
26
|
Alhazzani W, Alenezi F, Jaeschke RZ,
Moayyedi P and Cook DJ: Proton pump inhibitors versus histamine 2
receptor antagonists for stress ulcer prophylaxis in critically ill
patients: A systematic review and meta-analysis. Crit Care Med.
41:693–705. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Staubli SM, Oertli D and Nebiker CA:
Laboratory markers predicting severity of acute pancreatitis. Crit
Rev Clin Lab Sci. 52:273–283. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yang R, Tenhunen J and Tonnessen TI: HMGB1
and histones play a significant role in inducing systemic
inflammation and multiple organ dysfunctions in severe acute
pancreatitis. Int J Inflam. 2017(1817564)2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Dawar FU, Xiong Y, Khattak MNK, Li J, Lin
L and Mei J: Potential role of cyclophilin A in regulating cytokine
secretion. J Leukoc Biol. 102:989–992. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Dai SR, Li Z and Zhang JB: Serum
interleukin 17 as an early prognostic biomarker of severe acute
pancreatitis receiving continuous blood purification. Int J Artif
Organs. 38:192–198. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wang J, Shen Y, Zhong Z, Wu S and Zheng L:
Risk factors for post-endoscopic retrograde
cholangiopancreatography (ERCP) pancreatitis and the effect of
octreotide combined with nonsteroidal anti-inflammatory drugs on
preventing its occurrence. Med Sci Monit. 24:8964–8969.
2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Hackert T, Tudor S, Felix K, Dovshanskiy
D, Hartwig W, Simon WA and Werner J: Effects of pantoprazole in
experimental acute pancreatitis. Life Sci. 87:551–557.
2010.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Uehara S, Gothoh K, Handa H, Tomita H and
Tomita Y: Immune function in patients with acute pancreatitis. J
Gastroenterol Hepatol. 18:363–370. 2003.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhang T, Fan Y, Liu K and Wang Y: Effects
of different general anaesthetic techniques on immune responses in
patients undergoing surgery for tongue cancer. Anaesth Intensive
Care. 42:220–227. 2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Vaidya B, Shenton BK, Stamp S, Miller M,
Baister E, Andrews CD, Dickinson AJ, Perros P and Kendall-Taylor P:
Analysis of peripheral blood T-cell subsets in active
thyroid-associated ophthalmopathy: Absence of effect of
octreotide-LAR on T-cell subsets in patients with
thyroid-associated ophthalmopathy. Thyroid. 15:1073–1078.
2005.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Larussa T, Suraci E, Leone I, Nazionale I,
Abenavoli L, Galasso O, Amorosi A, Imeneo M and Luzza F: Short-term
therapy with celecoxib and lansoprazole modulates Th1/Th2 immune
response in human gastric mucosa. Helicobacter. 15:449–459.
2010.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Chrysant SG and Chrysant GS: Adverse
cardiovascular and blood pressure effects of drug-induced
hypomagnesemia. Expert Opin Drug Saf. 19:59–67. 2020.PubMed/NCBI View Article : Google Scholar
|
